CN Stock MarketDetailed Quotes

300026 Tianjin Chase Sun Pharmaceutical

Watchlist
  • 4.19
  • -0.11-2.56%
Market Closed Dec 13 15:00 CST
12.59BMarket Cap76.18P/E (TTM)

Tianjin Chase Sun Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Product Currency:CNY
2024/H1
Stock NameRevenueRatio
Prescription granules and tablets of traditional Chinese Medicine1.31B43.61%
Total special adjustments777.22M25.94%
Xuebijing injection454.22M15.16%
药械智慧供应链450.82M15.05%
Other business7.23M0.24%
Industry Currency:CNY
2024/H1
Stock NameRevenueRatio
Drugs2.04B68.09%
智慧供应链450.82M15.05%
Raw and auxiliary materials248.9M8.31%
medical apparatus172.48M5.76%
Other83.88M2.80%
Region Currency:CNY
2024/H1
Stock NameRevenueRatio
East China region932.17M31.11%
North China823.41M27.48%
Central China362.75M12.11%
Southwest area214.04M7.14%
South China200.11M6.68%
overseas market198.08M6.61%
Northwest region152.09M5.08%
Northeast area113.59M3.79%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme State-owned Enterprise Reform
State-owned Enterprise Reform
Intraday-1.75%